Alam says the promises of dramatic benefits for skin and hair are not worth the risk
*These statements have not been evaluated by the FDA
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
AOD 9604: Fat Metabolism Without the Muscle and Recovery Effects AOD 9604 targets fat metabolism more directly than either of the above, but the evidence base for visceral fat specifically is thinner than what exists for tesamorelin
Human trial BPC-157 was formally evaluated "in trials for inflammatory bowel disease" (PL-10, PLD-116, PL-14736
But when combinedcorrectlythey create a synergistic effect that accelerates recovery and supports healing at the cellular level. Abby Hand, MSN, FMCHC, Functional Health & Certified Epigenetics Expert, Saving Face Austin Why They Work Better Together While both BPC-157 and TB500 stimulate healing, they target different mechanisms within the body
